Description
Tremelimumab (Ticilimumab) is a fully human monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research.
Cat.No
A074
Name
Tremelimumab Biosimilar (Anti-CTLA-4 / CD152 Reference Antibody)
Chemical Properties
CAS
745013-59-6
Synonyms
Ticilimumab;Tremelimumab;(2S,5S,8S,11R,14S,17S,20S,23S,26S,29S)-17-[(2S)-2-Butanyl]-29-[{[(2S)-5-carbamimidamido-1-hydroxy-1-:CP-675206
pH value
Corresponds to reference standard: PASS
Non-reduced CE-SDS
>95%
SEC-HPLC
>95%
Isoelectric Point
Corresponds to reference standard
Bacterial Endotoxins Test
Residual Proteins of Host Cell
Exogenous Residual DNA
Residual protein A
Biological Activity
Osmolality
Corresponds to reference standard: PASS
Peptide mapping
Corresponds to reference standard: PASS
N-terminal sequence
Corresponds to reference standard: PASS
References
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131Fax: +86-21-61642470Email:
Website:
.png)